Properties (57)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:Company
|
gptkbp:acquisition |
Various pharmaceutical companies
|
gptkbp:awards |
Various industry awards
|
gptkbp:CEO |
gptkb:M._S._Bansal
|
gptkbp:certifications |
gptkb:FDA
EMA |
gptkbp:clinicalTrials |
Conducts clinical trials
|
gptkbp:communityEngagement |
Yes
|
gptkbp:communitySupport |
Local community support programs
|
gptkbp:corporateSocialResponsibility |
Active CSR initiatives
|
gptkbp:distribution |
Worldwide
|
gptkbp:employees |
Over 500
|
gptkbp:financialPerformance |
Consistent growth
|
gptkbp:focus |
Biopharmaceuticals
|
gptkbp:founded |
1990
|
gptkbp:headquarters |
gptkb:Ireland
|
https://www.w3.org/2000/01/rdf-schema#label |
Wockhardt Ireland Ltd.
|
gptkbp:industry |
Pharmaceuticals
|
gptkbp:innovation |
Yes
|
gptkbp:investmentFocus |
In research and development
|
gptkbp:location |
gptkb:Dublin
gptkb:Athlone Limerick |
gptkbp:market |
Global
Strong_market_presence_in_Asia Strong_market_presence_in_North_America Strong_market_presence_in_Europe |
gptkbp:marketingStrategy |
Focus on sustainability
Focus on digital transformation Focus on innovation Focus on customer satisfaction Focus on quality Focus on operational efficiency Focus on talent development Focus on global expansion Focus on strategic partnerships Focus on market diversification Focus on regulatory compliance |
gptkbp:parentCompany |
gptkb:Wockhardt_Ltd.
|
gptkbp:partnerships |
Various healthcare organizations
Collaborations with research institutions Collaborations with universities |
gptkbp:patentCitation |
Holds multiple patents
|
gptkbp:products |
Branded drugs
Vaccines Injectables OTC products Generic_drugs |
gptkbp:regulatoryCompliance |
Yes
|
gptkbp:researchAndDevelopment |
Yes
|
gptkbp:revenue |
Over €100 million
|
gptkbp:services |
Contract manufacturing
|
gptkbp:subsidiary |
gptkb:Wockhardt_UK_Ltd.
|
gptkbp:supplyChain |
Global supply chain
|
gptkbp:sustainabilityInitiatives |
Yes
|
gptkbp:training |
Yes
|
gptkbp:website |
www.wockhardt.com
|